Literature DB >> 20959497

Distinct genetic regions modify specific muscle groups in muscular dystrophy.

Kayleigh A Swaggart1, Ahlke Heydemann, Abraham A Palmer, Elizabeth M McNally.   

Abstract

Phenotypic expression in the muscular dystrophies is variable, even with the identical mutation, providing strong evidence that genetic modifiers influence outcome. To identify genetic modifier loci, we used quantitative trait locus mapping in two differentially affected mouse strains with muscular dystrophy. Using the Sgcg model of limb girdle muscular dystrophy that lacks the dystrophin-associated protein γ-sarcoglycan, we evaluated chromosomal regions that segregated with two distinct quantifiable characteristics of muscular dystrophy, membrane permeability and fibrosis. We previously identified a single major locus on murine chromosome 7 that influences both traits of membrane permeability and fibrosis in the quadriceps muscle. Using a larger cohort, we now found that this same interval strongly associated with both traits in all limb skeletal muscle groups studied, including the gastrocnemius/soleus, gluteus/hamstring, and triceps muscles. In contrast, the muscles of the trunk were modified by distinct genetic loci, possibly reflecting the embryological origins and physiological stressors unique to these muscle groups. A locus on chromosome 18 was identified that modified membrane permeability of the abdominal muscles, and a locus on chromosome 3 was found that regulated diaphragm and abdominal muscle fibrosis. Fibrosis in the heart associated with a region on chromosome 9 and likely reflects differential function between cardiac and skeletal muscle. These data underscore the complexity of inheritance and penetrance of single-gene disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959497      PMCID: PMC3026347          DOI: 10.1152/physiolgenomics.00172.2010

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  29 in total

1.  Genetic background influences muscular dystrophy.

Authors:  Ahlke Heydemann; Jill M Huber; Alexis Demonbreun; Michele Hadhazy; Elizabeth M McNally
Journal:  Neuromuscul Disord       Date:  2005-10       Impact factor: 4.296

Review 2.  Dystrophin, its interactions with other proteins, and implications for muscular dystrophy.

Authors:  James M Ervasti
Journal:  Biochim Biophys Acta       Date:  2006-06-07

3.  Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice.

Authors:  Ahlke Heydemann; Ermelinda Ceco; Jackie E Lim; Michele Hadhazy; Pearl Ryder; Jennifer L Moran; David R Beier; Abraham A Palmer; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

4.  Mind bomb 2, a founder myoblast-specific protein, regulates myoblast fusion and muscle stability.

Authors:  Marta Carrasco-Rando; Mar Ruiz-Gómez
Journal:  Development       Date:  2008-01-23       Impact factor: 6.868

Review 5.  Muscle diseases: the muscular dystrophies.

Authors:  Elizabeth M McNally; Peter Pytel
Journal:  Annu Rev Pathol       Date:  2007       Impact factor: 23.472

6.  Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.

Authors:  Stefania Assereto; Mauro Mastrototaro; Silvia Stringara; Elisabetta Gazzerro; Paolo Broda; Grazia Paola Nicchia; Maria Svelto; Claudio Bruno; Vincenzo Nigro; M P Lisanti; Antonio Frigeri; Carlo Minetti
Journal:  Cell Cycle       Date:  2008-05-12       Impact factor: 4.534

7.  NO more muscle fatigue.

Authors:  Ahlke Heydemann; Elizabeth McNally
Journal:  J Clin Invest       Date:  2009-03       Impact factor: 14.808

8.  Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

Authors:  A A Hack; C T Ly; F Jiang; C J Clendenin; K S Sigrist; R L Wollmann; E M McNally
Journal:  J Cell Biol       Date:  1998-09-07       Impact factor: 10.539

9.  Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex.

Authors:  Mariya M Kucherenko; Mario Pantoja; Andriy S Yatsenko; Halyna R Shcherbata; Karin A Fischer; Dariya V Maksymiv; Yaroslava I Chernyk; Hannele Ruohola-Baker
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

10.  Tnni3k modifies disease progression in murine models of cardiomyopathy.

Authors:  Ferrin C Wheeler; Hao Tang; Odessa A Marks; Tracy N Hadnott; Pei-Lun Chu; Lan Mao; Howard A Rockman; Douglas A Marchuk
Journal:  PLoS Genet       Date:  2009-09-18       Impact factor: 5.917

View more
  20 in total

1.  Interplay between heart and skeletal muscle disease in heart failure: the 2011 George E. Brown Memorial Lecture.

Authors:  Elizabeth M McNally; Jeffery A Goldstein
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

2.  Targeting latent TGFβ release in muscular dystrophy.

Authors:  Ermelinda Ceco; Sasha Bogdanovich; Brandon Gardner; Tamari Miller; Adam DeJesus; Judy U Earley; Michele Hadhazy; Lucas R Smith; Elisabeth R Barton; Jeffery D Molkentin; Elizabeth M McNally
Journal:  Sci Transl Med       Date:  2014-10-22       Impact factor: 17.956

3.  Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair.

Authors:  Kayleigh A Swaggart; Alexis R Demonbreun; Andy H Vo; Kaitlin E Swanson; Ellis Y Kim; John P Fahrenbach; Jenan Holley-Cuthrell; Ascia Eskin; Zugen Chen; Kevin Squire; Ahlke Heydemann; Abraham A Palmer; Stanley F Nelson; Elizabeth M McNally
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-09       Impact factor: 11.205

4.  Cardiac function in muscular dystrophy associates with abdominal muscle pathology.

Authors:  Brandon B Gardner; Kayleigh A Swaggart; Gene Kim; Sydeaka Watson; Elizabeth M McNally
Journal:  J Neuromuscul Dis       Date:  2015

Review 5.  Modifiers of heart and muscle function: where genetics meets physiology.

Authors:  Kayleigh A Swaggart; Elizabeth M McNally
Journal:  Exp Physiol       Date:  2013-11-08       Impact factor: 2.969

6.  Dusp6 is a genetic modifier of growth through enhanced ERK activity.

Authors:  Andy H Vo; Kayleigh A Swaggart; Anna Woo; Quan Q Gao; Alexis R Demonbreun; Katherine S Fallon; Mattia Quattrocelli; Michele Hadhazy; Patrick G T Page; Zugen Chen; Ascia Eskin; Kevin Squire; Stanley F Nelson; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

7.  LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.

Authors:  Kevin M Flanigan; Ermelinda Ceco; Kay-Marie Lamar; Yuuki Kaminoh; Diane M Dunn; Jerry R Mendell; Wendy M King; Alan Pestronk; Julaine M Florence; Katherine D Mathews; Richard S Finkel; Kathryn J Swoboda; Eduard Gappmaier; Michael T Howard; John W Day; Craig McDonald; Elizabeth M McNally; Robert B Weiss
Journal:  Ann Neurol       Date:  2013-02-20       Impact factor: 10.422

8.  Reduced IGF signaling prevents muscle cell death in a Caenorhabditis elegans model of muscular dystrophy.

Authors:  Kelly Hyunju Oh; Hongkyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 9.  Genetic mutations and mechanisms in dilated cardiomyopathy.

Authors:  Elizabeth M McNally; Jessica R Golbus; Megan J Puckelwartz
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 10.  Modifying muscular dystrophy through transforming growth factor-β.

Authors:  Ermelinda Ceco; Elizabeth M McNally
Journal:  FEBS J       Date:  2013-04-24       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.